First Episealer® Talus surgery performed in Israel

Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery in Israel with the ankle implant Episealer® Talus was successfully performed last week. Dr. Ezequiel Palmanovich performed the surgery at Meir Medical Center, assisted by Prof. Niek van Dijk with support from Episurf. Since previously, the Episealer® Knee technology is available in Israel.

“We are pleased with adding an additional market as this was the first Episealer® Talus surgery in Israel“, says Pål Ryfors, CEO Episurf Medical.

Prof. Niek van Dijk and the surgical team at Meir Medical Center, Israel.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Tags: